Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extended-spectrum beta-lactamases.

J E Patterson1

  • 1Department of Medicine, University of Texas Health Science Center at San Antonio, 78229-3900, USA. pattersonj@uthscsa.edu

Seminars in Respiratory Infections
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumo-peritoneum following PEG insertion: a clinical dilemma.

Acute medicine·2011
Same author

Extended-spectrum beta-lactamases. An overview.

Postgraduate medicine·2009
Same author

Acapella versus 'usual airway clearance' during acute exacerbation in bronchiectasis: a randomized crossover trial.

Chronic respiratory disease·2007
Same author

Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit.

Bone marrow transplantation·2007
Same author

Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance.

Chronic respiratory disease·2005
Same author

Risk factors for Candida species colonization of neonatal intensive care unit patients.

The Pediatric infectious disease journal·2001
Same journal

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

Seminars in respiratory infections·2003
Same journal

Environmental infection control of tuberculosis.

Seminars in respiratory infections·2003
Same journal

Mycobacterium tuberculosis: the treatment of active disease.

Seminars in respiratory infections·2003
Same journal

Pediatric tuberculosis.

Seminars in respiratory infections·2003
Same journal

Clinical and radiographic features of HIV-related tuberculosis.

Seminars in respiratory infections·2003
Same journal

Treatment of latent tuberculosis infection.

Seminars in respiratory infections·2003
See all related articles

Extended-spectrum beta-lactamases (ESBLs) in Klebsiella pneumoniae cause significant resistance to broad-spectrum cephalosporins. Controlling antibiotic use is crucial for managing these multidrug-resistant infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Increasing resistance to broad-spectrum cephalosporins in Klebsiella pneumoniae, especially in intensive care units globally.
  • Extended-spectrum beta-lactamases (ESBLs) are a primary mechanism driving this resistance.
  • Co-resistance to other antibiotic classes (aminoglycosides, fluoroquinolones) is common, limiting treatment options.

Purpose of the Study:

  • To highlight the growing problem of ESBL-producing Klebsiella pneumoniae.
  • To discuss the mechanisms and implications of ESBL-mediated resistance.
  • To emphasize the importance of prevention and control strategies.

Main Methods:

  • Literature review and synthesis of current knowledge on ESBLs in Klebsiella pneumoniae.

Related Experiment Videos

  • Analysis of resistance patterns and associated mechanisms.
  • Discussion of clinical and public health implications.

    • Main Results:

    • ESBLs confer resistance to multiple broad-spectrum beta-lactam antibiotics.
    • Co-transfer of resistance genes on plasmids leads to multidrug-resistant strains.
    • Carbapenems remain the drugs of choice for ESBL-producing Klebsiella pneumoniae infections.

    Conclusions:

    • Multidrug resistance in Klebsiella pneumoniae, driven by ESBLs, poses a significant global health threat.
    • Traditional infection control measures and judicious antibiotic stewardship are essential for controlling the spread of ESBLs.